News

Vinay Prasad, in surprise reversal, to rejoin FDA after abrupt departure

Less than weeks after stepping down, Prasad will return to lead CBER “at the FDA’s request,” according to an HHS spokesperson ...

Precigen shares jump after US FDA approves first therapy for rare respiratory disease

Precigen's immunotherapy for a rare respiratory disease has become the first treatment to win U.S. regulatory approval for ...
Healio2h

FDA approves Papzimeos as first therapy for recurrent respiratory papillomatosis

The FDA approved the adenoviral vector-based immunotherapy, zopapogene imadenovec-drba, for treatment of certain patients ...
Fierce Pharma15d

Vinay Prasad's exit signals FDA's probable slip toward more permissive regulation of cell and gene therapy: analyst

But this time, the unknown is hitting the industry in a different way from when Prasad was tapped to lead CBER less than three months ago.
MedPage Today on MSN2d

Soap Recall Over Sepsis Risk; FDA Rehires Vinay Prasad; NIH Reports Patient to ICE

DermaRite Industries is recalling certain lots of its over-the-counter soaps, antiseptics, and analgesics due to ...

Indian-origin Dr Vinay Prasad returns to FDA weeks after exit; Laura Loomer calls it 'egregious decision'

Dr Vinay Prasad, previously ousted from his FDA vaccine chief position due to criticism from Laura Loomer over past ...